Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares IssuedShares Outstanding
Ratios

Ensysce Biosciences (ENSC) Long-Term Debt Repayments (2022 - 2024)

Historic Long-Term Debt Repayments for Ensysce Biosciences (ENSC) over the last 3 years, with Q1 2024 value amounting to $485190.0.

  • Ensysce Biosciences' Long-Term Debt Repayments rose 1681.45% to $485190.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $485190.0, marking a year-over-year decrease of 5149.11%. This contributed to the annual value of $485190.0 for FY2024, which is 5149.11% down from last year.
  • Per Ensysce Biosciences' latest filing, its Long-Term Debt Repayments stood at $485190.0 for Q1 2024, which was up 1681.45% from $584857.0 recorded in Q2 2023.
  • Ensysce Biosciences' Long-Term Debt Repayments' 5-year high stood at $1.1 million during Q4 2022, with a 5-year trough of $415351.0 in Q1 2023.
  • Moreover, its 3-year median value for Long-Term Debt Repayments was $535023.5 (2023), whereas its average is $656987.5.
  • Over the last 5 years, Ensysce Biosciences' Long-Term Debt Repayments had its largest YoY gain of 1681.45% in 2024, and its largest YoY loss of 1681.45% in 2024.
  • Over the past 3 years, Ensysce Biosciences' Long-Term Debt Repayments (Quarter) stood at $1.1 million in 2022, then tumbled by 48.81% to $584857.0 in 2023, then fell by 17.04% to $485190.0 in 2024.
  • Its Long-Term Debt Repayments stands at $485190.0 for Q1 2024, versus $584857.0 for Q2 2023 and $415351.0 for Q1 2023.